338 related articles for article (PubMed ID: 3463886)
21. [Clinical evaluation of CA 19-9 for the detection of malignant tumors--a comparison with CEA and IAP].
Furukawa M; Kazaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T
Gan No Rinsho; 1984 Apr; 30(4):357-62. PubMed ID: 6587133
[TBL] [Abstract][Full Text] [Related]
22. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H
Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042
[TBL] [Abstract][Full Text] [Related]
23. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases.
Putzki H; Ledwoch J; Student A; Jablonski M; Heymann H
J Surg Oncol; 1988 Feb; 37(2):133-5. PubMed ID: 3278167
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
[TBL] [Abstract][Full Text] [Related]
25. Expression of tumour markers CA50, CEA and TPA in female breast carcinoma as related to histopathological findings and survival.
Eskelinen M; Lipponen P; Syrjänen K
Anticancer Res; 1992; 12(1):91-5. PubMed ID: 1567186
[TBL] [Abstract][Full Text] [Related]
26. [Predictive value of a tumor marker combination for the monitoring of ovarian cancer].
Lahousen M
Wien Klin Wochenschr; 1986 May; 98(10):319-25. PubMed ID: 3460273
[TBL] [Abstract][Full Text] [Related]
27. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
Björklund V; Björklund B
Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
[TBL] [Abstract][Full Text] [Related]
28. [Ferritin, CEA and TPA as tumor markers in breast neoplasms].
Bonanni F; Folco U; Giudici Cipriani A; Buffa E; Amedeo A; Bertolotto M; Rembado R; Barbetti V; Guglieri F
Minerva Med; 1985 Sep; 76(34-35):1533-4. PubMed ID: 4034052
[TBL] [Abstract][Full Text] [Related]
29. The clinical significance of serum CA 19-9 in patients with gastric and colorectal carcinoma and immunohistochemical visualization of CA 19-9 in tumor tissues.
Sekikawa K
Fukushima J Med Sci; 1985 Jun; 31(1):29-42. PubMed ID: 3866740
[No Abstract] [Full Text] [Related]
30. [Utility of CA19-9 and CEA as tumor marker in colorectal cancer--comparison between serum level and distribution].
Okuda K; Kodaira S; Watanabe M; Takami H; Teramoto T; Abe O; Iri H; Ino Y; Hirohashi S
Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):969-77. PubMed ID: 3463631
[No Abstract] [Full Text] [Related]
31. Comparison of a CEA-EIA assay based on monoclonal antibody with a CEA-RIA assay with polyclonal antiserum.
Orjasaeter H; Staab HJ; Heier HE; Hornung A; Kjørstad K; Luedin E; Rognum TO; Bell H
NIPH Ann; 1985 Jun; 8(1):13-26. PubMed ID: 3903552
[TBL] [Abstract][Full Text] [Related]
32. [Clinical significance of serum tumor markers (CEA, TPA, IAP and ferritin) in pulmonary tuberculosis].
Komatsu H
Kekkaku; 1987 Jan; 62(1):31-6. PubMed ID: 3573509
[No Abstract] [Full Text] [Related]
33. [Tumor markers in gastrointestinal cancer and its clinical significance].
Taguchi T; Ota J; Sumida S; Rii M
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3004-9. PubMed ID: 3479051
[TBL] [Abstract][Full Text] [Related]
34. [The sensitivity and specificity of tumor markers (CEA, ferritin, beta 2-MG, TPA, IAP, sialic acid) in malignant and non-malignant pulmonary diseases and their relation to smoking and sex].
Reshad K; Suzuki K; Inui K; Takahashi Y; Umemiya M; Nakano Y; Sakamoto M; Takeuchi Y; Shimada T
Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Nov; 23(11):1343-50. PubMed ID: 3912573
[No Abstract] [Full Text] [Related]
35. [New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
Indraccolo SR; Cecchi A; Thodos A; Brandi S; Carta G
Ann Ostet Ginecol Med Perinat; 1991; 112(1):36-40. PubMed ID: 1929097
[TBL] [Abstract][Full Text] [Related]
36. [Auxiliary value of TPA in diagnosing neoplastic diseases].
Mizushima Y; Nakamura F; Yokoyama A; Morikage T; Kawasaki S; Hoshino K; Maruyama M; Yamashita N; Yano S
Gan No Rinsho; 1986 Jun; 32(7):779-82. PubMed ID: 3735675
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
[TBL] [Abstract][Full Text] [Related]
38. Significance of carcinoembryonic and tissue polypeptide antigen determination in the diagnosis of metastases in breast cancer.
Kausitz J; Hupka S; Makaiová I; Michalíková B; Urbanová M; Bohunický L; Belovicová C
Neoplasma; 1986; 33(4):471-6. PubMed ID: 3762808
[TBL] [Abstract][Full Text] [Related]
39. [Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
Forti E; Wolf D; Melia M
Pathologica; 1985; 77(1049):241-9. PubMed ID: 3913892
[No Abstract] [Full Text] [Related]
40. [The tumor markers TPA and CEA in the after care of breast cancer].
Beaufort F; Fueger GF; Steiner H
Wien Med Wochenschr; 1985 Feb; 135(4):85-8. PubMed ID: 2986366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
